Celldex Therapeutics (CLDX) EPS (Basic) (2010 - 2026)
Celldex Therapeutics' (CLDX) quarterly EPS (Basic) came in at -$1.29 in Q1 2026, up 99.84% year-on-year from -$0.65 in Q1 2025, and up 21.8% quarter-over-quarter from -$1.65 in Q4 2025.
Celldex Therapeutics (CLDX) EPS (Basic) (2010 - 2026) Analysis & Trends
Celldex Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$1.29 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 99.84% year-over-year to -$1.29 in Q1 2026; TTM through Mar 2026 was -$4.91, a 99.82% increase from a year earlier, with the FY2025 full-year figure at -$9.96, up 99.59% from the prior year.
- EPS (Basic) climbed to -$1.29 in Q1 2026 per CLDX's latest filing, from -$1.65 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.49 in Q1 2022 and bottomed at -$1009.4 in Q3 2025.
- The 5-year median for EPS (Basic) is -$621.87 (2023), against an average of -$517.34.
- Across the five-year window, EPS (Basic) plunged 141703.71% in 2023 and surged 99.84% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$564.9 in 2022, then slumped by 58.23% to -$893.85 in 2023, then gained by 18.12% to -$731.87 in 2024, then jumped by 99.77% to -$1.65 in 2025, then increased by 21.8% to -$1.29 in 2026.
- Per Business Quant, the three latest CLDX EPS (Basic) figures stand at -$1.29 (Q1 2026), -$1.65 (Q4 2025), and -$1009.4 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn | -1.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 |
| Dec 31, 2025 | -1.65 |
| Sep 30, 2025 | -1,009.44 |
| Jun 30, 2025 | -967.04 |
| Mar 31, 2025 | -810.39 |
| Dec 31, 2024 | -731.87 |
| Sep 30, 2024 | -635.37 |
| Jun 30, 2024 | -542.90 |
| Mar 31, 2024 | -557.29 |
| Dec 31, 2023 | -893.85 |
| Sep 30, 2023 | -809.55 |
| Jun 30, 2023 | -645.50 |
| Mar 31, 2023 | -621.87 |
| Dec 31, 2022 | -564.90 |
| Sep 30, 2022 | -0.57 |
| Jun 30, 2022 | -0.77 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | -469.98 |
| Sep 30, 2021 | -0.45 |
| Jun 30, 2021 | -0.34 |